Allergy And Therapy

Journal of Molecular and Genetic medicine is an open access journal of allergy and therapy that publishes high-impact, cutting-edge clinical and translational research papers for all types of allergies and researchers interested in allergic diseases. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. Journal of Molecular and Genetic medicine intends to impart the enhanced clinical profits for human wellbeing from the trial and translational exploration performed utilizing molecular tools. Areas that are secured incorporate, yet are not restricted to, tumor science, immunology, neuroscience, cardiovascular disease, heredity and genomics, gene therapy and stem cells and regenerative medicine. OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 700+ peer-reviewed journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary people.